Form 4: Candel Therapeutics CEO Paul Peter Tak Sells Shares to Cover Tax Obligations
SEC Form 4
Candel Therapeutics CEO Paul Peter Tak sold 22,528 shares of common stock on July 17, 2024, at a price of $6.4726 per share to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On July 17, 2024, Paul Peter Tak, the CEO of Candel Therapeutics, Inc., sold 22,528 shares of common stock.
- The sale was executed at a price of $6.4726 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
- Following the transaction, Tak directly owns 330,735 shares of Candel Therapeutics.
- The sale was mandated by the Issuer's mandatory sell to cover policy.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't reflect a change in the executive's outlook on the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among executives. This transaction is not necessarily indicative of the executive's sentiment towards the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 07/17/2024 | Date of the stock sale transaction. |
| 07/19/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.